Search

everythinglearnresearchcommunity

for

Search:↓

Protein tyrosine kinases are key in male pattern baldness, affecting skin structure, hair growth, and immune responses.

Higher serum androgens contribute to male pattern baldness.

There's no clear link between female pattern hair loss, insulin resistance, and metabolic syndrome.

Men with androgenetic alopecia have unique metabolomic patterns that could help develop targeted treatments.

Some breast cancer treatments cause hair loss similar to male pattern baldness, which can be improved with minoxidil.

Targeting specific genes in certain pathways may help treat male pattern baldness.

PRP therapy significantly improves hair thickness and density in male pattern baldness.

Certain gut bacteria may increase or decrease the risk of male pattern baldness.

Alcohol-free minoxidil 5% is effective and safe for treating male pattern hair loss.

Platelet-rich plasma may improve hair density and count in male pattern hair loss, but more high-quality research is needed.

Supplemented Erzhi Wan may help regrow hair in male pattern baldness by affecting certain cell signaling pathways.

Topical cetirizine may help increase hair length in male pattern baldness and could be an alternative to minoxidil with fewer side effects.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Botulinum toxin type A is a safe and effective treatment for male pattern baldness.

The Ar/miR-221/IGF-1 pathway is involved in male pattern baldness, with miR-221 potentially being a new target for treatment.

There's no significant link between blood fat levels and male pattern baldness.

There's no significant link between hair loss from male pattern baldness and early heart disease.

Ketoconazole shampoo improves hair growth and reduces oil similarly to minoxidil in male pattern hair loss.

Combining PRP with topical minoxidil is the most effective for increasing hair density in male pattern baldness.

Certain fats in the blood are linked to an increased risk of male pattern baldness.

Parthenolide promotes hair growth in mice and may influence pathways related to male pattern baldness.

Topical procyanidin B2 significantly increases hair count and is a safe treatment for male pattern baldness.

Fibrosis in the bulge area of hair follicles can cause hair thinning in male pattern baldness, and drugs that inhibit fibrosis might help reverse this.

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

Testosterone causes hair loss in AGA mice, which are good for testing baldness treatments, and both minoxidil and cyproterone acetate can prevent this hair loss.

Topical minoxidil and oral finasteride and dutasteride are the most effective treatments for male and female pattern hair loss, but study quality varies.

Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.

Platelet-rich plasma treatment significantly improved hair density and regrowth in both men and women suffering from pattern hair loss, with even better results when combined with certain medications.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Minoxidil, finasteride, and PRP are the most effective and accessible treatments for male pattern hair loss.